RGEN
187.49 USD
-1.59%
Today
+1.28%
1D
Market is closed
Sun
Closed
Mon
4:30 PM ~ 10:59 PM
Tue
4:30 PM ~ 10:59 PM
Wed
4:30 PM ~ 10:59 PM
Thu
4:30 PM ~ 10:59 PM
Fri
4:30 PM ~ 10:59 PM
Sat
Closed
Information
Name
Repligen Corp
Currency
USD
Market Cap
11.40B
Avg Daily Volume
1.19M
52 Week High
198.87 USD
52 Week Low
100.99 USD
Trading Hours
See hours
Business Summary
Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
Top News
Repligen
+5.10%
Repligen Corporation to Present at Jefferies Global Healthcare Conference
tradingview.com
2h ago
Repligen
+5.10%
EQT_Corp
-0.15%
RangeResou
-1.42%
Matador
-1.14%
Healthcare.Services
-1.13%
Devon
-1.68%
Remitly.Global
+1.77%
Cushman&Wakefield
+10.09%
Caseys
+0.71%
BootBarn
+6.25%
ScottsMiracle-Gro
+6.33%
RealReal
+1.69%
GE.Vernova
-7.33%
MP_Materials
-0.34%
Aehr.Systems
-5.87%
Amprius.Technologies
-1.35%
AmericanEx
+2.83%
LPL_Financial
+5.09%
Dave.Inc
-0.06%
Ecolab
+1.77%
APiGroup
+0.11%
CleanHarbors
+4.87%
Genmab
+1.67%
Curtiss-Wright
-1.32%
Generac
-4.58%
Novanta
+0.32%
OracleCorp
-2.47%
Everpure.Inc
-3.19%
Credo.Technology
-6.83%
UnitySoftware
+2.03%
Dynatrace
+0.21%
JonesLangLaSalle
+4.17%
Zeta.Global
+0.39%
William Blair refreshes stock Conviction List with 5 additions, 3 removals
tradingview.com
2d ago
Repligen
+5.10%
Weekly Recap: Higher 2026 guidance and phased manufacturing restructuring
tradingview.com
2d ago
Show more
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
